News & Analysis on Clinical Trial Services & Contract Research And Development
More details have emerged over the US Food and Drug Administration's (FDA's) failure to vet the Chinese manufacturing plant implicated in the Baxter heparin scare - the agency mistook it for an already-inspected plant, it turns out.
A new recombinant pig liver esterase (PLE) biocatalyst that sidesteps concerns about the safety of animal-derived versions has been launched by DSM Pharma Chemicals.
Concerns have been building across North America about the safety of transdermal patches for delivering the highly potent narcotic analgesic fentanyl.
A nanoparticle-based delivery system is being developed in the UK as a potential means of bypassing the blood brain barrier and improve the treatment of central nervous system diseases such as brain cancer.